Skip to content
10-K

Annual Report

MEDRESPONSE CORP.

0001477932-17-004531

← back to feed
Filed
Sep 18, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2016 · Sep 15, 2017 9.56M sh
Operating Cash Flow FY 2016 · Dec 31, 2016 −$7.7K
Operating Cash Flow FY 2016 · Dec 31, 2015 −$12.93K
Cash And Equivalents FY 2016 · Dec 31, 2016 $862
Cash And Equivalents FY 2016 · Dec 31, 2015 $100
Cash And Equivalents FY 2016 · Dec 31, 2014 $13.63K
Stockholders Equity FY 2016 · Dec 31, 2016 −$27.6K
Stockholders Equity FY 2016 · Dec 31, 2015 −$16.97K
Stockholders Equity FY 2016 · Dec 31, 2014 $8.28K
Stockholders Equity FY 2016 · Dec 31, 2013 $1.83K
Current Liabilities FY 2016 · Dec 31, 2016 $28.47K
Current Liabilities FY 2016 · Dec 31, 2015 $17.07K
Total Liabilities FY 2016 · Dec 31, 2016 $28.47K
Total Liabilities FY 2016 · Dec 31, 2015 $17.07K
Current Assets FY 2016 · Dec 31, 2016 $862
Current Assets FY 2016 · Dec 31, 2015 $100
Total Assets FY 2016 · Dec 31, 2016 $862
Total Assets FY 2016 · Dec 31, 2015 $100
Net Income FY 2016 · Dec 31, 2016 −$10.63K
Net Income FY 2016 · Dec 31, 2015 −$37.25K
Net Income FY 2016 · Dec 31, 2014 −$15.15K
Operating Income FY 2016 · Dec 31, 2016 −$9.95K
Operating Income FY 2016 · Dec 31, 2015 −$30.53K